Millennium Management’s Abiomed Inc ABMD Stock Holding History

Millennium Management’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-9,614	Closed	-$2.36M	–	7445
2022 Q3	$2.36M	Sell	9,614 -70,474	-88%	-$19M	﹤0.01%	3601
2022 Q2	$19.8M	Buy	80,088 +58,173	+265%	+$15.7M	0.01%	1319
2022 Q1	$7.26M	Buy	21,915 +10,068	+85%	+$3.1M	﹤0.01%	2522
2021 Q4	$4.25M	Sell	11,847 -26,137	-69%	-$8.83M	﹤0.01%	3070
2021 Q3	$12.4M	Sell	37,984 -22,847	-38%	-$7.74M	0.01%	1795
2021 Q2	$19M	Buy	60,831 +41,031	+207%	+$12.6M	0.01%	1244
2021 Q1	$6.31M	Buy	19,800 +14,513	+275%	+$4.64M	﹤0.01%	2333
2020 Q4	$1.71M	Sell	5,287 -9,937	-65%	-$2.75M	﹤0.01%	3357
2020 Q3	$4.22K	Buy	15,224 +12,408	+441%	+$3.57M	0.01%	1995
2020 Q2	$680K	Buy	2,816 +562	+25%	+$113K	﹤0.01%	3223
2020 Q1	$327K	Sell	2,254 -237,386	-99%	-$39.4M	﹤0.01%	3128
2019 Q4	$40.9M	Buy	239,640 +190,659	+389%	+$35.3M	0.05%	466
2019 Q3	$8.71M	Sell	48,981 -24,897	-34%	-$5.38M	0.01%	1374
2019 Q2	$19.2M	Sell	73,878 -70,117	-49%	-$18.6M	0.03%	815
2019 Q1	$41.1M	Buy	143,995 +73,787	+105%	+$24.5M	0.06%	415
2018 Q4	$22.8M	Buy	+70,208	New	+$24.4M	0.04%	650
2018 Q3	–	Sell	-196,014	Closed	-$77.3M	–	4400
2018 Q2	$80.2M	Sell	196,014 -60,719	-24%	-$22M	0.1%	242
2018 Q1	$74.7M	Sell	256,733 -197,706	-44%	-$50.1M	0.1%	276
2017 Q4	$85.2M	Buy	454,439 +76,286	+20%	+$14.2M	0.12%	198
2017 Q3	$63.8M	Sell	378,153 -90,744	-19%	-$13.7M	0.1%	267
2017 Q2	$67.2M	Buy	468,897 +55,783	+14%	+$7.5M	0.12%	213
2017 Q1	$51.7M	Sell	413,114 -80,384	-16%	-$9.32M	0.09%	297
2016 Q4	$55.6M	Buy	493,498 +440,090	+824%	+$51M	0.12%	229
2016 Q3	$6.87M	Sell	53,408 -162,310	-75%	-$19.4M	0.01%	1144
2016 Q2	$23.6M	Buy	215,718 +67,349	+45%	+$6.7M	0.05%	453
2016 Q1	$14.1M	Buy	148,369 +75,880	+105%	+$6.41M	0.04%	638
2015 Q4	$6.54M	Sell	72,489 -8,778	-11%	-$745K	0.01%	1182
2015 Q3	$7.54M	Sell	81,267 -104,653	-56%	-$9.22M	0.01%	1098
2015 Q2	$12.2M	Buy	185,920 +37,649	+25%	+$2.5M	0.02%	859
2015 Q1	$10.6M	Sell	148,271 -798,899	-84%	-$43.4M	0.02%	979
2014 Q4	$36M	Sell	947,170 -192,895	-17%	-$6.08M	0.08%	345
2014 Q3	$28.3M	Buy	1,140,065 +1,214	+0.1%	+$30.8K	0.07%	350
2014 Q2	$28.6M	Buy	1,138,851 +297,678	+35%	+$6.93M	0.08%	318
2014 Q1	$21.9M	Buy	841,173 +196,345	+30%	+$5.43M	0.06%	409
2013 Q4	$17.2M	Sell	644,828 -41,530	-6%	-$1.03M	0.05%	422
2013 Q3	$13.1M	Buy	686,358 +52,482	+8%	+$1.2M	0.04%	557
2013 Q2	$13.7M	Buy	+633,876	New	+$12.7M	0.04%	472

Other funds holding ABMD

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Millennium Management's ABMD Position: Q4 2022 in Review

Millennium Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 9,614 shares — an estimated $2.36M sold.

Millennium Management first reported a position in ABMD in Q2 2013 and held it in 37 quarters. The position peaked at $85.2M in Q4 2017. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

Millennium Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
Millennium Management sold 9,614 Abiomed Inc shares in Q4 2022, an estimated $2.36M.
Millennium Management first reported a position in Abiomed Inc in Q2 2013 and held it in 37 quarters.
Millennium Management's Abiomed Inc position peaked at $85.2M in Q4 2017.
8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Millennium Management's 13F filing for Q4 2022, filed 14 Feb 2023.